Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.43.5 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.6.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FP.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GS.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
BA.1.21.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.37NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.39NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EE.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
ES.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.41NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.6.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.39NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.141NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.591NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.468NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.131 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.586NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.366NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.380NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.148NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.382NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.356NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.376NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.607NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.163NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.337NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.158NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-19361.6US
B.1.602NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.289NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.7.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDHNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.15.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.273NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.13 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.358NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.60NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.159NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.625NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HD.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GY.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HH.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KN.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used